About US
Contact us
-
DOJ pricing probe threatens $1B-plus fines, but few generics makers will face charges: AnalystsNews that the Justice Department is preparing criminal charges in its long-standing investigation into generic drug pricing hit those companies hard Thursday afternoon, wiping out $8.5 billion in mark2016/11/10
-
Eisai wins NICE backing for older Halaven but still isn't happy about LenvimaAfter weighing new data and a discount, England’s drug-cost watchdogsbackedEisai’s Halavento treat advanced breast cancer, making it the first drugto win a green lightin breast cancer in nearly a deca2016/11/9
-
NICE says Merck KGaA's Erbitux falls short in mouth cancer, despite new discount, dataCiting “significant uncertainties” about Merck KGaA's Erbitux for head and neck cancer, England’s cost-effectiveness watchdogs have shot down the treatment in a newassessment. Currently available thro2016/11/9
-
Teva asks FDA to raise the bar on new Copaxone copiesTeva may be at a court’s mercy when it comes to IP protection for its long-lasting multiple sclerosis therapy, Copaxone. But that doesn’t mean the company is just sitting around. The Israeli drugmake2016/11/8
-
With addiction rates rising, NY counties join march to sue opioid manufacturersWith addiction rates continuing to climb, officials in New York's Broome County say they're looking to do what states such as Illinois and New Hampshire have done: sue opioid manufacturers for mislead2016/11/8
-
GE Healthcare and Valneva collaboration results in cell culture medium for vaccine productionGE Healthcare’s Life Sciences business and integrated vaccine biotech company Valneva SE have successfully collaborated to optimise virus productivity in Valneva’s EB66 cell-line, a proprietary techno2016/11/7
-
Lonza opens drug product services laboratory in SwitzerlandChemicals and biotechnology company Lonza has opened its pharmaceutical Drug Product Services laboratory in the Stücki Science Park Basel (CH), Switzerland. The new 1,300m2facility will initially car2016/11/7
-
M&As this week: Canopy Growth Corporation, Novogen, Karo PharmaCanadian cannabis companyCanopy Growth Corporationhas completed the acquisition of medical cannabis company Vert Medical. The purchase consideration for the acquisition includes repayment of the targ2016/11/4
-
Merck and American Cancer Society release report on cancer death in womenMerck and the American Cancer Society (ACS) have released a report on causes of cancer-related mortality in women. Titled 'The Global Burden of Cancer in Women', the report is a result of the partner2016/11/4
-
UK team of health experts deployed to help control global disease outbreaksA UK team of health experts comprising clinicians, scientists and academicians will be deployed to respond to requests from countries worldwide to help control disease outbreaks within 48 hours. Know2016/11/3